Drug Development Double-Blinded Randomized Clinical Trials Cancer Treatment Trials Phase 2 Clinical Trials Drug Safety Patient Safety Phase III Clinical Trials
The CHMP’s positive opinion sets the stage for final EU Commission approval to replace high-global-warming-potential propellant with Honeywell’s lower-carbon alternative throughout AstraZeneca’s regional supply